Ignite Creation Date:
2025-12-24 @ 1:33 PM
Ignite Modification Date:
2026-04-16 @ 5:28 AM
Study NCT ID:
NCT05722795
Status:
RECRUITING
Last Update Posted:
2025-07-09
First Post:
2022-04-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Use of Imatinib to Convert Triple Negative Breast Cancer Into ER-positive Breast Cancer (I-CONIC)
Sponsor:
Vastra Gotaland Region
Organization:
Organization Data
Organization:
Class:
OTHER_GOV
Study ID:
EudraCT 2020-005200-19
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None